ES2196251T3 - Agente terapeutico para el tratamiento de dermatitis canina rebelde. - Google Patents

Agente terapeutico para el tratamiento de dermatitis canina rebelde.

Info

Publication number
ES2196251T3
ES2196251T3 ES97122864T ES97122864T ES2196251T3 ES 2196251 T3 ES2196251 T3 ES 2196251T3 ES 97122864 T ES97122864 T ES 97122864T ES 97122864 T ES97122864 T ES 97122864T ES 2196251 T3 ES2196251 T3 ES 2196251T3
Authority
ES
Spain
Prior art keywords
canine
dermatitis
therapeutic agent
rebel
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97122864T
Other languages
English (en)
Inventor
Tomiya Uchino
Katsushige Yamada
Fumiyoshi Okano
Masahirro Satoh
Isao Kawakami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Application granted granted Critical
Publication of ES2196251T3 publication Critical patent/ES2196251T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

ESTA INVENCION ES UN AGENTE TERAPEUTICO COMPUESTO POR INTERFERON GA CANINO, PARA LA DERMATITIS CANINA INTRATABLE.
ES97122864T 1997-03-06 1997-12-24 Agente terapeutico para el tratamiento de dermatitis canina rebelde. Expired - Lifetime ES2196251T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5161297 1997-03-06

Publications (1)

Publication Number Publication Date
ES2196251T3 true ES2196251T3 (es) 2003-12-16

Family

ID=12891734

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97122864T Expired - Lifetime ES2196251T3 (es) 1997-03-06 1997-12-24 Agente terapeutico para el tratamiento de dermatitis canina rebelde.

Country Status (9)

Country Link
US (1) US5955069A (es)
EP (1) EP0862918B1 (es)
KR (1) KR100530125B1 (es)
AU (1) AU734887B2 (es)
CA (1) CA2219275C (es)
DE (1) DE69720410T2 (es)
ES (1) ES2196251T3 (es)
NZ (1) NZ329461A (es)
ZA (1) ZA9711660B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU734887B2 (en) * 1997-03-06 2001-06-28 Toray Industries, Inc. Therapeutic agent and treatment for canine intractable dermatitis
US6197292B1 (en) * 1997-03-06 2001-03-06 Toray Industries, Inc. Therapeutic agent and treatment for canine intractable dermatitis
DE69838667T2 (de) * 1997-08-01 2008-10-30 Toray Industries, Inc. Verfahren zur stabilisierung nützlicher proteine und nützliche proteinhaltige mittel
EP1582216A4 (en) * 2002-12-26 2010-04-21 Asubio Pharma Co Ltd CURE FOR PEMPHIGOID
CN107383207A (zh) * 2017-08-09 2017-11-24 芜湖英特菲尔生物制品产业研究院有限公司 一种重组犬长效干扰素α及制备此长效干扰素的融合蛋白及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991007984A1 (en) * 1989-12-01 1991-06-13 Children's Medical Center Corporation Treatment of atopic disorders with gamma-interferon
JPH09234085A (ja) * 1995-12-28 1997-09-09 Toray Ind Inc イヌインターフェロンγの製造法
AU734887B2 (en) * 1997-03-06 2001-06-28 Toray Industries, Inc. Therapeutic agent and treatment for canine intractable dermatitis

Also Published As

Publication number Publication date
EP0862918B1 (en) 2003-04-02
DE69720410T2 (de) 2003-11-27
CA2219275A1 (en) 1998-09-06
AU4840697A (en) 1998-09-10
KR19980079554A (ko) 1998-11-25
US5955069A (en) 1999-09-21
NZ329461A (en) 1999-05-28
AU734887B2 (en) 2001-06-28
ZA9711660B (en) 1998-06-25
EP0862918A3 (en) 2000-02-23
DE69720410D1 (de) 2003-05-08
CA2219275C (en) 2011-08-02
KR100530125B1 (ko) 2006-04-17
EP0862918A2 (en) 1998-09-09

Similar Documents

Publication Publication Date Title
GT199800177A (es) Combinacion eficaz para el tratamiento de la impotencia .
ES2191152T3 (es) Terapia combinada para el tratamiento de psicosis.
ES2156603T3 (es) Medicamentos a base de una mezcla sinergetica de metronidazol y de clindamicina.
ES2164842T3 (es) Procedimiento para la preparacion de composiciones de microcapsulas.
MX9302618A (es) Antagonistas de endotelina de fenil sulfonamidas.
ES2164182T3 (es) Benzociclopentanoxazolidinonas que contienen heteroatomos con actividad antibacteriana.
PT871730E (pt) Combinacao de pdgf, kgf, igf e igfbp para cicatrizacao de ferimentos
ES2148582T3 (es) Fungicidas para la represion de la enfermedad de mal de pie de plantas.
ES526102A0 (es) Mejoras introducidas en el objeto de la patente de invencion principal n 518.044 por: mejoras en la fabricacion de municion, preferentemente para el empleo contra objetivos cubiertos
ES2304795T3 (es) Anticuerpos agonistas para el receptor de trombopoyetina y sus usos terapeuticos.
ES2159977T3 (es) Esteres de (met)acrilato de organosiloxano-polioles, proceso para su preparacion y su empleo como composiciones de revestimiento susceptibles de curado por radiacion.
PA8484301A1 (es) Formulaciones farmaceuticas de liberacion controlada
GT199800037A (es) Combinaciones para diabetes de sulfonilurea - glitazona.
ES2155844T3 (es) Preparacion de n-alquilcarboxilatos de piperidinilo 3,4,4-trisustituidos e intermedios, utiles como antagonistas de opiaceos.
ES2188795T3 (es) Agentes antimicrobianos benzoxacina.
HN1998000124A (es) Terapia de combinacion
ES2055587T3 (es) El uso de agonistas selectivos de gaba-b como agentes antitusivos.
PA8452701A1 (es) Agonistas de prostaglandinas
HN1998000088A (es) Tratamiento de resistencia a la insulina
MX9601368A (es) Metodo de tratamiento de la reestenosis por terapia genica.
PA8587801A1 (es) Isomeros posicionales de interferon alfa 2-a monopegilado
EE200300559A (et) Osteopontiini kasutamine neuroloogiliste haigusteraviks ja/või vältimiseks
ES2196251T3 (es) Agente terapeutico para el tratamiento de dermatitis canina rebelde.
ES2154725T3 (es) Nuevos compuestos de sililo y su utilizacion.
UY27451A1 (es) 2,5-diamidoindoles sustituidos y su utilización